RMC-7977 is a potent pan-RAS(ON) inhibitor. It blocks RAS, inhibiting cell viability, thereby affecting the MAPK pathway.
RMC-7977 MOA:Targeting RAS/MAPK Pathway for Pancreatic Ductal Adenocarcinoma
RMC-7977 is a potent pan-RAS(ON) inhibitor. It blocks RAS, inhibiting cell viability, thereby affecting the MAPK pathway.